Skip to main content
OSCR logo

OSCR · Oscar Health, Inc. · Financials

Track OSCR — free
$27.57 -2.27 (-7.61%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$8.57B
Shares
310.69M
Volume · Nov 18 7.4M Avg daily vol (3M) 5.28M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$11.7B +27.5%
FY2025 Revenue FY2019–FY2025
Net Income
-$443.15M -1842.5%
FY2025 Net Income FY2019–FY2025
Operating Margin
-3.39% -4pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$1.69 -1790%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
$1.09B +11.9%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$19B – $19.3B $17.47B $11.7BG $9.18BG $5.86B $3.96B $1.84B $462.8M $488.19M
— $17.16B $11.47B $8.97B $5.69B $3.87B $1.83B $455.04M $468.86M
— $27.5M $28.89M $32.15M $30.69M $15.28M $265.08M $166.66M $110.68M
— $2.63B $2.05B $1.76B $1.43B $1.26B — — —
— $27.47M $28.89M $32.15M $30.69M $15.28M $14.61M $11.29M $6.9M
— $936.99M -$396.36M $57.27M -$235.62M -$589.87M -$544.48M -$402.27M -$259.39M
— — -3.39% 0.62% -4.02% -14.88% -29.61% -86.92% -53.13%
— $964.46M -$367.47M $89.41M -$204.92M -$574.58M -$529.88M -$390.98M -$252.49M
— $13.72M $17.6M $23.73M $24.6M $22.62M $4.72M $3.51M $0
— -$18.79M -$23.34M -$105K -$7.08M $2.42M -$1.2M — —
— — — — — -$1.27M $212K $1.24M $481K
— $904.48M -$437.3M $33.43M -$267.3M -$610.08M -$570.58M -$405.78M -$259.39M
— $48.76M $5.61M $7.31M $3.29M -$523K $846K $1.05M $1.79M
— $855.47M -$443.15M $25.43M -$270.73M -$606.28M -$572.61M -$406.83M -$261.18M
— — -3.79% 0.28% -4.62% -15.3% -31.14% -87.9% -53.5%
— $247K $248K $689K $134K -$3.28M $1.18M $0 $0
— — -$443.15M $25.43M -$270.73M -$606.28M -$572.61M -$414.24M -$261.18M
— $797.42M -$423.29M $22.3M -$259.7M -$612.32M -$577.16M -$405.92M -$261.17M
USD/shares — $2.65 -$1.69 $0.11 -$1.22 -$2.85 -$3.20 -$14.16 -$9.06
USD/shares — $2.47 -$1.69 $0.10 -$1.22 -$2.85 -$3.20 -$14.16 -$9.06
shares — — 262.39M 240.39M 221.66M 212.48M 178.97M 29.26M 28.81M
shares — — 262.39M 265.85M 221.66M 212.48M 178.97M 29.26M 28.81M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2021: $2.99M in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent debt carrying amount 2026-09-30 USD 432,410,000 10-Q filed 2026-11-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.21×
EV/EBIT
—
Peer median 18.44×
P/E (TTM)
11.16×
Peer median 27.79×
Price/Sales (TTM)
0.49×
Peer median 0.28×
Price/Book
3.85×
Peer median 2.60×

Peer medians compare against the 7 similar-size Healthcare Plans companies (of 13 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1568651 CUSIP 687793109 13F (30d) 434 filings 403 filers Visit website Investor relations